TY - JOUR
T1 - Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy
AU - Fujise, Kenshiro
AU - Okubo, Mariko
AU - Abe, Tadashi
AU - Yamada, Hiroshi
AU - Nishino, Ichizo
AU - Noguchi, Satoru
AU - Takei, Kohji
AU - Takeda, Tetsuya
N1 - Funding Information:
Funding and additional information—This work was supported by JSPS KAKENHI (18K07198 and 19KK0180), grants from Wesco Scientific Promotion Foundation and Ryobi Teien Memory Foundation for T. T. This work was also supported by Intramural Research Grant for Neuronal and Psychiatric Disorders of NCNP (29-4, 2-5 for T. T. and I. N., 28-6, 30-9 for S. N.), and AMED under Grant Numbers JP19ek0109285h0003 for I. N. and S. N. K. T. was supported by JSPS KAKENNHI (19H03225). M. O. was supported by Grant-in-Aid for JSPS Research Fellow (19J12028).
Publisher Copyright:
© 2020 THE AUTHORS.
PY - 2021
Y1 - 2021
N2 - Membrane remodeling is required for dynamic cellular processes such as cell division, polarization, and motility. BAR domain proteins and dynamins are key molecules in membrane remodeling that work together for membrane deformation and fission. In striated muscles, sarcolemmal invaginations termed T-tubules are required for excitation-contraction coupling. BIN1 and DNM2, which encode a BAR domain protein BIN1 and dynamin 2, respectively, have been reported to be causative genes of centronuclear myopathy (CNM), a hereditary degenerative disease of skeletal muscle, and deformation of T-tubules is often observed in the CNM patients. However, it remains unclear how BIN1 and dynamin 2 are implicated in T-tubule biogenesis and how mutations in these molecules cause CNM to develop. Here, using an in cellulo reconstitution assay, we demonstrate that dynamin 2 is required for stabilization of membranous structures equivalent to T-tubules. GTPase activity of wild-type dynamin 2 is suppressed through interaction with BIN1, whereas that of the disease-associated mutant dynamin 2 remains active due to lack of the BIN1-mediated regulation, thus causing aberrant membrane remodeling. Finally, we show that in cellulo aberrant membrane remodeling by mutant dynamin 2 variants is correlated with their enhanced membrane fission activities, and the results can explain severity of the symptoms in patients. Thus, this study provides molecular insights into dysregulated membrane remodeling triggering the pathogenesis of DNM2-related CNM.
AB - Membrane remodeling is required for dynamic cellular processes such as cell division, polarization, and motility. BAR domain proteins and dynamins are key molecules in membrane remodeling that work together for membrane deformation and fission. In striated muscles, sarcolemmal invaginations termed T-tubules are required for excitation-contraction coupling. BIN1 and DNM2, which encode a BAR domain protein BIN1 and dynamin 2, respectively, have been reported to be causative genes of centronuclear myopathy (CNM), a hereditary degenerative disease of skeletal muscle, and deformation of T-tubules is often observed in the CNM patients. However, it remains unclear how BIN1 and dynamin 2 are implicated in T-tubule biogenesis and how mutations in these molecules cause CNM to develop. Here, using an in cellulo reconstitution assay, we demonstrate that dynamin 2 is required for stabilization of membranous structures equivalent to T-tubules. GTPase activity of wild-type dynamin 2 is suppressed through interaction with BIN1, whereas that of the disease-associated mutant dynamin 2 remains active due to lack of the BIN1-mediated regulation, thus causing aberrant membrane remodeling. Finally, we show that in cellulo aberrant membrane remodeling by mutant dynamin 2 variants is correlated with their enhanced membrane fission activities, and the results can explain severity of the symptoms in patients. Thus, this study provides molecular insights into dysregulated membrane remodeling triggering the pathogenesis of DNM2-related CNM.
UR - http://www.scopus.com/inward/record.url?scp=85101839038&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101839038&partnerID=8YFLogxK
U2 - 10.1074/JBC.RA120.015184
DO - 10.1074/JBC.RA120.015184
M3 - Article
C2 - 33187981
AN - SCOPUS:85101839038
SN - 0021-9258
VL - 296
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
M1 - 100077
ER -